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In tro duc ti on
Type 1 diabetes mellitus (T1DM) is a common chronic
disease in childhood. Fifty percent of subjects with T1DM
are diagnosed within the first 15 years of life (1). The
Diabetes Control and Complications Trial and the
Epidemiology of Diabetes Interventions and Complications
study demonstrated that improving metabolic control in
children and adolescents with T1DM reduced the risk of
diabetic complications (2,3). Previous studies have
attributed poor metabolic control among adolescents to
their changing physiology (pubertal growth and
development) as well as to behavioral and adherence issues
(4,5,6). Intensified insulin therapy resulted in a better
metabolic control and reduced diabetic complications (7).
Good metabolic control is crucial for the prevention of 
long-term diabetic complications (8). This can be achieved
by daily self-monitoring of blood glucose (SMBG), multiple
daily insulin injections, regular HbA1c measurements, and
attention to physical activity. Exercise is an essential
component in blood glucose regulation for T1DM patients,
along with insulin management (9). The American Diabetes
Association (ADA) emphasized the importance of ongoing
education in prevention of and screening for diabetes
complications (10). Diabetes education programs have small
to medium beneficial effects on metabolic control (11,12)
ABS TRACT
Objective:Preventing long-term diabetic complications requires good
metabolic control, especially in type 1 diabetes mellitus (T1DM). We
describe the metabolic control of T1DM and the factors affecting it
among children and adolescents attending the Pediatric Clinic at King
Abdul-Aziz University Hospital. 
Methods: A retrospective cross-sectional study was conducted on
T1DM children and adolescents who had attended the Pediatric Clinic at
King Abdul-Aziz University Hospital from 2006 to 2010. Both clinical and
laboratory data were reviewed for the enrolled cases. The mean age of the
patients was 12.5±4.1 years. Ages ranged from 1 to 18 years (n=484:
male=213, female= 271).  38.6% of the patients were pre-pubertal and
61.4% - pubertal. The patients were categorized into 3 age groups as 1-6
years (10.3%), 7-12 years (33.5%) and 13-18 years (56.2%).  
Results: The overall mean HbA1c was 9.4±2.4% and the duration of
patient follow-up was 26±17 months. 10.3% of the patients were on
conventional insulin regimens and 89.7% - on intensive insulin therapy.
31.4% had satisfactory HbA1c according to the American Diabetes
Association guidelines. The duration of T1DM was 2.9±1.4 years.  The
patients with diabetes duration ≤2 years (45%) had a mean HbA1c of
8.7±1.8% and those with diabetes duration >2 years (55%) had a mean
HbA1c value of  9.8±2.3% (p< 0.001). 
Conclusions: The metabolic control of T1DM children in our cohort was
less satisfactory than in other studies. We recommend the promotion of
physical exercise and family educational programs to improve the
metabolic control of T1DM pediatric patients in our population. 
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(13). We describe the current level of metabolic control in
children and adolescents attending the pediatric endocrine
clinic at King Abdul-Aziz University (KAAU) Hospital and the
impact of different factors such as age, pubertal stage,
gender, duration of diabetes, insulin regimen, family
diabetes education, and physical exercise on the metabolic
control of T1DM pediatric patients in our population.
Methodology
Study Design and Subjects
This retrospective cross-sectional study was
conducted on all children and adolescents who had
attended the pediatric endocrine clinic at KAAU Hospital
from 2006 to 2010. Inclusion criteria were: follow-up period
in the pediatric endocrine clinic for more than 3 months,
patient age between 1 and 18 years, and an HbA1c value
>6.5%. A total of 547 patients were retrospectively
reviewed and 63 were excluded from the study due to age
(becoming ≥18 years during the study period) or to a
follow-up period of less than 3 months. Thus, the study
population consisted of 484 children and adolescents with
T1DM, aged from 1 to 18 years. Mean, standard deviation
(SD) and median for age values were 12.5±4.1 and 13
years, respectively. The mean (±SD) follow-up period was
26±17 months (range: 8-48 months). A total of 72 (15%)
patients were followed up for 4 years. Of the study
population, 213 were males (44%) and 271 were females
(56%); 187 were pre-pubertal (38.6%) and 297 were
pubertal (61.4%).
Duration of T1DM, attendance to diabetes education
sessions and seminars, insulin regimen, rate of SMBG,
Tanner staging, regularity of physical exercise, and serum
HbA1c were reviewed from patient clinical and laboratory
records. We categorized all patients into three age groups:
toddlers and pre-school children (1-6 years), 50/484
(10.3%); school children (7-12 years), 162/484 (33.5%); and
adolescents and young adults (13-18 years), 272/484
(56.2%). Prior to data entry into the study database for
analysis, all collected variables were reviewed by a
pediatric endocrinology consultant at KAAU for data quality
assurance. In the present study, we followed the ADA
guidelines for target HbA1c levels per age group. The ADA
recommends a target HbA1c of approximately 8.5% in
toddlers, between 7.5% and 8.5% in pre-school children,
≤8% in school children, and ≤7.5% in adolescents and
young adults (10). In contrast, the more stringent guidelines
of the International Society for Pediatric and Adolescent
Diabetes recommend that a target HbA1c level of <7.5%
should be achieved without succumbing into episodes of
severe hypoglycemia (14). 
Insulin Regimens and SMGB
The protocol used in the pediatric endocrine clinic at
KAAU regarding insulin regimens for T1DM children and
adolescents is conventional insulin regimen for both toddlers
and pre-school children and intensive insulin regimen for
children >6 years and all adolescents. Conventional insulin
regimen was defined as the administration of 2 injections of
insulin/day as a combination of regular short-acting and
intermediate-acting insulin before breakfast and dinner,
coupled with SMBG and adjustments of insulin dosage in
response to the individual's metabolic control. Importantly,
hyperglycemia (depending on age) was corrected with 
short- or rapid-acting insulin. Intensive insulin regimen was
defined as either receiving 3 insulin injections/day, and in
addition receiving a basal bolus of insulin, or being on an
insulin pump. Insulin basal bolus was defined as a rapid- 
or short-acting insulin injection before each meal and either a
single long-acting basal dose or two intermediate-acting doses
to cover the basal need for insulin between meals and during
the night. Patient rate of SMBG was reviewed from the clinical
records. Values of HbA1c were based on measurement at
regular intervals (3 months) and then averaged to create a 
4-year mean exposure variable for each enrolled subject. At
KAAU, HbA1c is measured by the SEIMENS Dimension clinical
chemistry system using a GLU Flex reagent cartridge. The
laboratory test is the hexokinase method. 
Diabetes Education and Physical Exercise
Patient compliance to physical exercise and diabetes
education sessions, as well as the weekly frequency of
physical exercise, was assessed from a review of the hospital
records of the enrolled subjects.  The patients were divided
into 3 categories with respect to physical exercise: the first
group did not indulge in physical exercise; the second group
performed physical exercise 1-2 times/week; and the third
group performed physical exercise 3-4 times/week.
Compliance to physical exercise was defined as continuous
physical exercise lasting ≥30 minutes/day both indoors and
outdoors. Compliance to diabetes education events was
defined as attendance of ≥1 session, symposium, seminar,
lecture, and clinical appointment/month. 
Statistical Analysis
The data were compiled from KAAU Hospital phoenix
database. SPSS version 16.0 software was used for the
analysis. Continuous variables were represented as mean
(±SD) and categorical variables as percentages. Student 
t-test, Mann-Whitney U test, and Kruskal-Wallis test were
used for comparative evaluation. When appropriate, 
Chi-square test and cross tabulations were applied for the
analysis of categorical data. Spearman’s rank correlation
coefficient was used to study the correlation between
HbA1c and age. A p-value of <0.05 was taken as
203
Al-Agha A et al.
Metabolic Control in Diabetic Patientsstatistically significant for individual variables. As this was
primarily a study of the entire population of T1DM pediatric
patients who had attended the pediatric endocrine clinic at
KAAU Hospital, sample size calculations were not
performed a priori. This study was approved by the
biomedical ethics department at KAAU, Faculty of Medicine.
Results
Metabolic control became more challenging as pediatric
patients advanced in age. Gender did not influence the
metabolic control in our cohort (Table 1). The overall HbA1c
was 9.4±2.4 and 8.8% (mean±SD and median, respectively).
Metabolic control was less satisfactory in the pubertal group
compared to the pre-pubertal group (HbA1c 10±2.6 vs.
8.5±1.7%, p<0.001). Of a total of 484 patients, 152 (31.4%)
had satisfactory HbA1c values according to the ADA
guidelines. In our cohort, 50/484 were on conventional
insulin regimens (10.3%) and 434/484 were on intensive
insulin therapy (89.7%); only 18/434 (4.1%) of those on
intensive insulin therapy had an insulin pump. Metabolic
control among the toddlers and pre-school age group was
more satisfactory when compared to the school and
adolescent age groups (Table 2). A positive correlation was
found between HbA1c and age (r=+0.3, p<0.001). In our
cohort, 138/484 patients (28.51%) were compliant to
diabetes education programs. HbA1c levels were 8.2±0.5 for
those who were compliant to diabetes education programs
and 10±1.9 for those who were not compliant. The
difference between these two groups was significant
(p<0.05). Of a total of 484, 187 (38.6%) patients were
compliant with SMBG ≥4 times/day; 119 of the 187 (63.6%)
subjects were also compliant to the diabetes education
exercises. The mean duration of T1DM was 2.9±1.4 years. In
218 of the 484 patients (45%), diabetes duration was ≤2
years and the mean HbA1c value was 8.7±1.8% In 266
(55%), diabetes duration was >2 years (mean HbA1c 9.8
±2.3%). The difference between HbA1c values was
significant (p<0.001). The duration of T1DM was 2.5±1.1
years in those with controlled HbA1c (according to the ADA
guidelines) and 3±1.2 years in those with uncontrolled
HbA1c. The difference was significant (p<0.05). According to
the clinical records, only 35 of the 484 enrolled children
(7.2%) performed regular physical exercise 3 to 4 times a
week, 124 (25.6%) exercised 1 to 2 times a week, and the
majority 325 (67.2%) did not perform any physical exercise
on a regular basis. The mean HbA1c levels in these groups
were 7.1±0.6, 8.2±0.7, and 10.3±2.7, respectively, with a 
p value of <0.001 (Kruskal-Wallis test). 
Discussion
Several studies have reported on the metabolic control
of T1DM children and adolescents (15,16,17,18), but this is
the first to examine the metabolic control among T1DM
pediatric patients in Saudi Arabia and has relevance to the
planning and improvement of care in developed and less
well-developed settings serving children and adolescents
with T1DM. Specifically, this study demonstrates that
attention to both physical exercise and diabetes education
programs can be effectively established and that they are
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Tab le  1. Comparison of well and poorly controlled T1DM children and
adolescents according to the ADA guidelines
Well controlled Poorly controlled p value
(n=152) (n=332)
Age (years) 10.3±4.1 13.4±3.6 < 0.001†
Gender (female)  89 (58.6) 182 (54.8) NS
HbA1c (%) 7.2±0.5 10.4±2.3 < 0.001†
Duration of T1DM (years) 2.4±1.2 3±1.3 < 0.05*
Insulin regimen  120 (79) 314 (94.6) < 0.05*
(intensive insulin therapy) 
Compliance to   128 (84.2) 10 (3) < 0.001†
educational activities
SMBG≥4 times/day 102 (67.1) 85 (25.6) < 0.05*
No physical exercise 61 (40.1) 264 (79.5) < 0.001†
Exercise (1 to 2/week) 67 (44.1) 57 (17.2) < 0.001†
Exercise (3 to 4/week) 24 (15.8) 11 (3.3) < 0.001†
Values are given as numbers of patients and percentages (%) or as mean ±SD; 
*significant; †highly significant
T1DM: type 1 diabetes mellitus, HbA1c: hemoglobin A1c, ADA: the American Diabetes
Association, SMBG: self-monitoring of blood glucose, NS: non significant
Tab le  2.  HbA1c control among the 3 age groups of the present study
Age group Number (%)  HbA1c  Number (%) 
of patients       of patients      
with good 
metabolic control*
Toddlers and pre- 50 (10.3) 8.4±1.5 32 (64)
school children 
(1 to 6 years)
School children 162 (33.5)  8.8±1.9 75 (46.3)
(7 to 12 years)
Adolescents and  272 (56.2) 10±2.7 45 (16.5) 
young adults 
(13 to 18 years)
Values are given as numbers of patients and percentages (%) or as mean ±SD.
*According to the ADA guidelines for target HbA1c in T1DM pediatric patients.
T1DM: type 1 diabetes mellitus, HbA1c: hemoglobin A1c, ADA: the American
Diabetes Association
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despite the fact that several confounding factors play a role
in metabolic control, this study shows that conventional
insulin therapy may still be an appropriate therapeutic
option in managing young children (≤6 years) with T1DM.  
Good metabolic control in T1DM pediatric patients
reduces the incidence of complications and delays the
progression of existing complications (19). It is also
essential for normal growth and development (20). In our
cohort, insulin regimens were not the only factor influencing
metabolic control of T1DM pediatric patients. Lack of
physical exercise, negligence to adhere to daily SMBG and
to diabetes education programs were other contributing
factors. Prevalence of T1DM among children and
adolescents in Saudi Arabia was found to be 109.5/100 000
and this country has the lowest reported prevalence rate
compared to  some other countries in children <6 years of
age (21). This might explain why few patients in our cohort
were younger than 6 years of age.
Intensive insulin therapy is the method of choice in
managing T1DM pediatric patients (7,22). Paradoxically,
there was a higher percentage of subjects receiving
intensive insulin therapy in the poor control group. The
reason for this is that the majority of our cohort (89.7%)
was on intensive insulin therapy, which precludes precise
comparisons between conventionally and intensively
treated patients. Furthermore, the KAAU endocrine
pediatric clinic prefers to start children on intensive insulin
therapy as early as possible (around the age of 7 years) in
order to improve their metabolic control and reduce the risk
of diabetic complications. Initiation of such therapy in
young children (≤6 years) is limited by problems related to
non-acceptance of multiple injections due to fear of
needles, fear of both the child and his/her parents of severe
hypoglycemic attacks, especially in those who have had a
past history of seizures during their sleep, unpredictability
of a toddler's dietary intake and activity level, difficulty of
adherence to daily SMBG and regular measurements of
HbA1c, and lack of regular exercise. Subcutaneous insulin
infusion therapy may provide yet another solution for some
patients, but without government subsidy, this type of
treatment is not affordable for most families (23). Indeed,
very few families in our cohort (4.1%) could afford insulin
pump therapy. 
Several studies reported that metabolic control was
worse in adolescents compared to younger children
(16,24). In our cohort, younger children had a better control
compared to adolescents. Interestingly, T1DM patients ≤6
years of age who were on conventional insulin therapy had
good metabolic control. Intensive insulin therapy is the
preferred therapeutic approach in managing children and
adolescents with T1DM (7,22). However, conventional
insulin regimens consisting of two insulin injections daily
may still be an appropriate therapeutic option for children
≤6 years of age, particularly for families who cannot afford
intensive insulin therapy. This choice has to be made
together with the patient and his/her parents upon
consideration of several factors such as: age; acceptance
of a restricted versus flexible diet; acceptance of a fixed
versus flexible but multiple insulin injections between
snacks and meals; the cultural and intellectual background
of the subject and of the family; compliance; and a history
of a partial remission phase. Both Tonella et al (16) and
Dorchy et al (17) reported that no significant difference was
observed between HbA1c levels of conventionally versus
intensively treated patients. Nonetheless, it has been
shown that intensive insulin treatment may result in a better
metabolic control and cause less complications when
compared with conventional approaches (25,26). However,
compliance to intensive regimens has been shown to be
weaker than compliance to conventional regimens,
suggesting a mismatch between the treatment regimen
proposed by the clinician and the extent to which patients
and their families can manage diabetes (27).
Several studies conducted on children and adolescents
with T1DM have demonstrated that both patient and family
education were associated with a reduction in number of
hospitalizations, emergency room visits, and a reduction in
overall healthcare expenses (28,29). Diabetes education is
not a one-time event that occurs at diagnosis. Indeed,
many studies have shown that to be effective, educational
interventions need to be both continuous and regular. Only
then can these efforts lead to improved HbA1c values and
decreased hospitalization rates (15,27,28,29,30). The ADA
recommends that T1DM children and adolescents,
especially those who are highly active, should monitor their
blood glucose levels ≥4 times/day, (10). In the present
study, families compliant to diabetes education events
appreciated the value of SMBG and were able to manage
their children's T1DM with greater success. Specialized
pediatric dietitians can give more appealing advice to
children and this will ultimately improve their overall
adherence to a T1DM-suitable lifestyle (15). 
The ADA, Center for Disease Control and the American
College of Sports Medicine all recommend that children
and adolescents with T1DM should have a minimum of 30
to 60 minutes of exercise/day (10). In our cohort also,
patients with T1DM who exercised regularly, enjoyed a
better metabolic control. Michaliszyn et al. have reported
that greater fitness levels predicted better metabolic
control in adolescents with T1DM (18). Benefits of physical
exercise in T1DM children and adolescents include
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weight control, improved physical fitness, improved
cardiovascular fitness with lower pulse, lower blood
pressure, and improved lipid profile (10,31). Herbst et al
demonstrated that the frequency of regular physical activity
was associated with lower HbA1c levels, but interestingly,
without increasing the risk of severe hypoglycemia (32).
Nonetheless, 10-20% of hypoglycemic episodes are
associated with exercise, thus, frequent blood glucose
monitoring is imperative (10).
The duration of T1DM and also the age of the patient
affected the metabolic control of children and adolescents
with T1DM in our cohort. Those with a <2 years duration of
diabetes had lower HbA1c levels compared to those who
had longer diabetes duration. Flück et al (24) reported that
metabolic control was worse in pubertal adolescents
compared to pre-pubertal children and also reported that
patients with a duration of diabetes <2 years had better
metabolic control than those with a longer duration. In our
cohort, gender did not affect the metabolic control of
children and adolescents with T1DM, in contrast to findings
reported in several studies (17,24). Among those on
intensive insulin therapy in our cohort, good metabolic
control was achieved in 46.3% of the patients who were
younger than 13 years, while only 16.5% of those who were
older than 13 years had a good metabolic control. 
Our study had some limitations. Firstly, the unequal
distribution of patients among age groups in our population
precludes precise comparisons. Secondly, in this
retrospective study, we were not able to assess either the
rates of hypoglycemia, a parameter which is important
particularly for T1DM patients on intensive insulin therapy,
or the nutritional/dietary status and life style of the patients,
except for their practice of physical exercise. 
From the results of this study, we conclude that the
best therapeutic approach in pediatric patients with T1DM
is intensive insulin therapy. However, other factors such as
duration of diabetes, attendance to both diabetic education
programs and physical exercise sessions also affect
metabolic control in children and adolescents with T1DM.
Emphasis must be made on the importance of diabetes
education in helping families improve their children's
metabolic control.
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